glp-1 substance abuse IUPHAR review – Glucagon-like peptide-1 (GLP-1) and use disorders: An emerging pharmacotherapeutic target GLP-1 weight-loss drugs show early

PMID: 8699133

The treatment reduced periorbital wrinkles by 55%, outperforming placebo and vitamin K cream, with 70% of participants reporting improved firmness and clarity (Abdulghani et al., 1998)

These results depend on taking the medicine exactly as prescribed

The trans-kingdom battle between donor and recipient gut microbiome influences fecal microbiota transplantation outcome

Prenatal infection leads to more severe illness, because the immature immune system is unable to slow down replication by tachyzoites, allowing continued damage to tissues

By increasing glutathione levels in the body, glutathione IV treatment can help improve skin pigmentation and promote a brighter, more youthful appearance